Global Genome Editing Market Segment Forecasts 2021-2028: Market Expansion of 22.9% CAGR Predicted from 2021-2028, Reaching Market Size of USD 19.4 Billion by 2028
Friday, September 10, 2021
DUBLIN, Sept. 9, 2021 /PRNewswire/ -- The "Global Genome Editing Market Size, Share & Trends Analysis Report by Technology (CRISPR, ZFN, TALEN), by Delivery Method, by Application, by Mode, by End-use, by Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
The global genome editing market size is expected to reach USD 19.4 billion by 2028. The market is expected to expand at a CAGR of 22.9% from 2021 to 2028. The success of CRISPR/Cas9 technology in 2020 coupled with technological advances in Transcription Activator-Like Effector Nucleases (TALENs) and Zinc-finger Nucleases (ZFNs) with respect to efficiency has driven the market.
Research communities are exploring the potential of gene-modification tools like CRISPR as a potential rapid screening solution for the COVID-19 genome. For instance, in December 2020, researchers from Gladstone Institutes developed a CRISPR-based test that uses smartphones to deliver results. Similarly in June 2020, researchers from Stanford University have developed -PAC-MAN a gene-modification tool based on CRISPR technology. This tool destroys SARS-CoV-2 inside human cells.
Increasing application of the gene-modification tools in therapeutic research has resulted in the rising number of advanced therapeutics entering clinical trials. Furthermore, the use of artificial intelligence to advance the implementation of novel gene modification systems exhibits great potential for the technology developer. This is anticipated to greatly favor the market revenue in the foreseeable future.
Genome Editing Market Report Highlights
-- The CRISPR/Cas9 technology segment accounted for the significant revenue
share in 2020
-- The CRISPR/Cas9 technology has proven its efficiency as a promising
gene-editing tool owing to its advantages over conventional gene
modification methods
-- One of the significant advantages includes simultaneous modification of
multiple target genes using this technology
-- The ex-vivo delivery method accounted for a major share owing to its
ease of DNA modification which resulted in its wide application for
genome editing purposes
-- Genetic engineering, particularly, cell line engineering dominated the
market
-- High penetration of gene-manipulation tools in stem cell research has
contributed to this dominance
-- The application of CRISPR technology has enhanced the productivity of
CHO cell lines consequently increasing its application in
biopharmaceutical production
-- Besides, animal genetic engineering is witnessing the growing
application of gene-alteration tools for various purposes such as the
development of animal models to mirror human diseases
-- Moreover, the Cas protein system is gaining traction in the development
of point-of-care diagnostics, thereby driving investment flow in
diagnostic applications
-- Biotechnology and pharmaceutical companies are the key end-users of the
market as these are adopted these technologies for the development of
novel therapeutics to a major extent
-- Also, the COVID-19 pandemic has driven the investments in this space to
develop rapid molecular diagnostic tests based on gene editing by
biotechnology companies
-- North America dominated the 2020 global market owing to the strong
research as well as the commercial base for various gene alteration
tools
-- Moreover, the U.S. is the major contributor in the region with the high
adoption of molecular scissor tools across research
-- This is indicated by the increasing number of genome editing-based
research publications in the country
-- In Asia Pacific, the market is anticipated to witness the fastest growth
rate over the forecast period
-- China is reported to be the first country to have successfully
transferred genetically edited cells into humans, to boost immunity and
treat lung cancer, thereby driving the market
-- Licensing agreements is the major strategy undertaken by operating
companies in this space to strengthen their market position
Key Topics Covered:
Chapter 1 Genome Editing Market: Research Methodology
Chapter 2 Genome Editing Market: Executive Summary
Chapter 3 Genome Editing Market: Industry Outlook
Chapter 4 Genome Editing Market: Technology Business Analysis
Chapter 5 Genome Editing Market: Delivery Method Business Analysis
Chapter 6 Genome Editing Market: Application Business Analysis
Chapter 7 Genome Editing Market: End-Use Business Analysis
Chapter 8 Genome Editing Market: Mode Business Analysis
Chapter 9 Genome Editing Market: Regional Business Analysis
Chapter 10 Genome Editing Market: Competitive Landscape
10.1 Strategy Framework
10.2 Market Participation Categorization
10.3 Strategic Alliance Analysis
10.4 Recent Developments & Impact Analysis
10.5 List of Potential End-users
10.6 Company Profiles
-- Merck KGaA
-- Cibus
-- Recombinetics, Inc
-- Sangamo
-- Editas Medicine
-- Precision Biosciences
-- CRISPR THERAPEUTICS
-- Intellia Therapeutics, Inc.
-- Caribou Biosciences, Inc
-- Cellectis
-- AstraZeneca
-- Takara Bio Inc.
-- Horizon Discovery Group
For more information about this report visit https://www.researchandmarkets.com/r/x0yk2y
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
View original content:https://www.prnewswire.com/news-releases/global-genome-editing-market-segment-forecasts-2021-2028--market-expansion-of-22-9-cagr-predicted-from-2021-2028--reaching-market-size-of-usd-19-4-billion-by-2028--301372386.html
SOURCE Research and Markets
|
|
|
|
|
 |
Asetek - Mandatory Notification of Trade | Jan 22, 2026
|
|
BC.GAME to Host "Stay Untamed" Night During Abu Dhabi's Packed Web3 Summit Week | Jan 22, 2026
|
|
Tomorrowland Brings the Magic to Shanghai for a Spectacular First Indoor Edition in China | Jan 22, 2026
|
|
Rent Manager Earned Best Real Estate Software Product Award and Multiple Review Badges from G2 Platform | Jan 22, 2026
|
|
Auburn University's Applied Research Institute Expands Advanced Manufacturing Capabilities with CF3D Enterprise Cell | Jan 22, 2026
|
|
California Divorce Mediation Center Unveils Modern Website Redesign | Jan 22, 2026
|
|
AMPERA ANNOUNCES LOCATION FOR GLOBAL HEADQUARTERS | Jan 22, 2026
|
|
Gemmy Alerts Customers: Fake Websites Target Holiday Decorators | Jan 22, 2026
|
|
Immutable Announces First Co-Founder-Hosted Live Webinar: How to Dominate Your Steam Launch | Jan 22, 2026
|
|
Culture and tourism sectors thrive in Xiamen | Jan 22, 2026
|
|
|
